504 related articles for article (PubMed ID: 19297134)
21. Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek University Hospital.
Souli M; Kontopidou FV; Papadomichelakis E; Galani I; Armaganidis A; Giamarellou H
Clin Infect Dis; 2008 Mar; 46(6):847-54. PubMed ID: 18269335
[TBL] [Abstract][Full Text] [Related]
22. [Investigation of plasmid-mediated AmpC beta-lactamase types in Klebsiella spp. and Escherichia coli isolates resistant or intermediate to cefoxitin].
Demirbakan H; Midilli K; Oğünç D; Ozen N; Ongüt G; Dağlar D; Mutlu D; Ozhak B; Colak D
Mikrobiyol Bul; 2008 Oct; 42(4):545-51. PubMed ID: 19149075
[TBL] [Abstract][Full Text] [Related]
23. Development of a real-time SYBRGreen PCR assay for rapid detection of acquired AmpC in Enterobacteriaceae.
Brolund A; Wisell KT; Edquist PJ; Elfström L; Walder M; Giske CG
J Microbiol Methods; 2010 Sep; 82(3):229-33. PubMed ID: 20600365
[TBL] [Abstract][Full Text] [Related]
24. The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC.
Haldorsen B; Aasnaes B; Dahl KH; Hanssen AM; Simonsen GS; Walsh TR; Sundsfjord A; Lundblad EW
J Antimicrob Chemother; 2008 Oct; 62(4):694-702. PubMed ID: 18583329
[TBL] [Abstract][Full Text] [Related]
25. Extended-spectrum beta-lactamase (ESBL)-producing enterobacteria: factors associated with infection in the community setting, Auckland, New Zealand.
Moor CT; Roberts SA; Simmons G; Briggs S; Morris AJ; Smith J; Heffernan H
J Hosp Infect; 2008 Apr; 68(4):355-62. PubMed ID: 18353497
[TBL] [Abstract][Full Text] [Related]
26. The use of cefepime for treating AmpC β-lactamase-producing Enterobacteriaceae.
Tamma PD; Girdwood SC; Gopaul R; Tekle T; Roberts AA; Harris AD; Cosgrove SE; Carroll KC
Clin Infect Dis; 2013 Sep; 57(6):781-8. PubMed ID: 23759352
[TBL] [Abstract][Full Text] [Related]
27. [Genotype distribution of extended-spectrum beta-lactamases and AmpC beta-lactamases produced in Escherichia coli isolated from men with urinary infection].
Wang WP; Shao HF; Wang JN; Zhang XW; Shi LN
Zhonghua Nan Ke Xue; 2006 Nov; 12(11):1000-3. PubMed ID: 17146926
[TBL] [Abstract][Full Text] [Related]
28. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study.
Mosqueda-Gómez JL; Montaño-Loza A; Rolón AL; Cervantes C; Bobadilla-del-Valle JM; Silva-Sánchez J; Garza-Ramos U; Villasís-Keever A; Galindo-Fraga A; Palacios GM; Ponce-de-León A; Sifuentes-Osornio J
Int J Infect Dis; 2008 Nov; 12(6):653-9. PubMed ID: 18511321
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain.
Miró E; Agüero J; Larrosa MN; Fernández A; Conejo MC; Bou G; González-López JJ; Lara N; Martínez-Martínez L; Oliver A; Aracil B; Oteo J; Pascual A; Rodríguez-Baño J; Zamorano L; Navarro F
Eur J Clin Microbiol Infect Dis; 2013 Feb; 32(2):253-9. PubMed ID: 22956023
[TBL] [Abstract][Full Text] [Related]
30. Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality.
Peña C; Gudiol C; Calatayud L; Tubau F; Domínguez MA; Pujol M; Ariza J; Gudiol F
J Hosp Infect; 2008 Feb; 68(2):116-22. PubMed ID: 18226420
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of carbapenem resistance among a collection of Enterobacteriaceae clinical isolates in a Texas city.
Bennett JW; Mende K; Herrera ML; Yu X; Lewis JS; Wickes BL; Jorgensen JH; Murray CK
Diagn Microbiol Infect Dis; 2010 Apr; 66(4):445-8. PubMed ID: 20226336
[TBL] [Abstract][Full Text] [Related]
32. Multiresistant Enterobacteriaceae: new threat of an old problem.
Pitout JD
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):657-69. PubMed ID: 18847404
[TBL] [Abstract][Full Text] [Related]
33. Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered in a French hospital.
Mammeri H; Eb F; Berkani A; Nordmann P
J Antimicrob Chemother; 2008 Mar; 61(3):498-503. PubMed ID: 18250231
[TBL] [Abstract][Full Text] [Related]
34. Clinical laboratory detection of AmpC β-lactamase: does it affect patient outcome?
Rand KH; Turner B; Seifert H; Hansen C; Johnson JA; Zimmer A
Am J Clin Pathol; 2011 Apr; 135(4):572-6. PubMed ID: 21411779
[TBL] [Abstract][Full Text] [Related]
35. [Qnr-type quinolone resistance in extended-spectrum beta-lactamase producing enterobacteria in Abidjan, Ivory Coast].
Guessennd N; Bremont S; Gbonon V; Kacou-Ndouba A; Ekaza E; Lambert T; Dosso M; Courvalin P
Pathol Biol (Paris); 2008; 56(7-8):439-46. PubMed ID: 18926644
[TBL] [Abstract][Full Text] [Related]
36. [Recent evolution and characterization of extended-spectrum beta-lactamase producing enterobacteria in the CHU of Nice (2005-2007)].
Giraud-Morin C; Fosse T
Pathol Biol (Paris); 2008; 56(7-8):417-23. PubMed ID: 18848404
[TBL] [Abstract][Full Text] [Related]
37. Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agents.
Mendes RE; Rhomberg PR; Bell JM; Turnidge JD; Sader HS
Diagn Microbiol Infect Dis; 2009 Apr; 63(4):415-25. PubMed ID: 19249175
[TBL] [Abstract][Full Text] [Related]
38. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.
Ben-Ami R; Rodríguez-Baño J; Arslan H; Pitout JD; Quentin C; Calbo ES; Azap OK; Arpin C; Pascual A; Livermore DM; Garau J; Carmeli Y
Clin Infect Dis; 2009 Sep; 49(5):682-90. PubMed ID: 19622043
[TBL] [Abstract][Full Text] [Related]
39. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.
Luzzaro F; Brigante G; D'Andrea MM; Pini B; Giani T; Mantengoli E; Rossolini GM; Toniolo A
Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415
[TBL] [Abstract][Full Text] [Related]
40. Institutional spread of clonally related Serratia marcescens isolates with a novel AmpC cephalosporinase (S4): a 4-year experience in Taiwan.
Yu WL; Ko WC; Cheng KC; Chen HE; Lee CC; Chuang YC
Diagn Microbiol Infect Dis; 2008 Aug; 61(4):460-7. PubMed ID: 18455901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
